Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2021 Feb 16;9(5):2060–2067.e2. doi: 10.1016/j.jaip.2021.02.006

Table 1.

Risk of T cell lymphopenia (TCL) or SCID Relative to NBS Profile

NBS Profile SCID Risk# TCL Risk*
NICU Not NICU All NICU Not NICU All
Undetectable TREC on Initial NBS 0.05 (1/20) 0.47 (7/15) 0.22 (8/35) 1.0 (14/14) 0.93 (14/15) 0.97 (28/29)
OOR but detectable TREC levels on two serial specimens in the absence of a normal result 0.006 (1/156) 0.0 (0/46) 0.005 (1/202) 0.84 (92/109) 0.91 (42/46) 0.86 (134/155)
Total 0.01 2/176 0.11 (7/61) 0.04 (9/237) 0.86 (106/123) 0.92 (56/61) 0.88 (162/184)
*

TCL Risk calculated using denominator of infants within a particular NBS profile who had flow cytometry testing completed with TCL defined as CD3 <2500

#

SCID Risk calculated using denominator of all infants within a particular NBS profile